review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Jason Wasiak | Q28356593 |
Heather Cleland | Q28356656 | ||
Fiona Campbell | Q54165792 | ||
P2860 | cites work | Measuring inconsistency in meta-analyses | Q27860655 |
Meta-analysis in clinical trials | Q27860779 | ||
Treatment of partial-thickness burns: a prospective, randomized trial using Transcyte | Q31106212 | ||
Initial management of a major burn: II--assessment and resuscitation | Q33979703 | ||
First aid and treatment of minor burns | Q35809874 | ||
A global study of hospitalized paediatric burn patients | Q36128995 | ||
Clinical comparison of commercially available Biobrane preparations | Q39524645 | ||
Principles of burn dressings | Q39838821 | ||
Prospective Randomized Treatments for Burned Hands: Nonoperative Vs. Operative Preliminary Report | Q41056009 | ||
Safety and efficacy of TransCyte for the treatment of partial-thickness burns. | Q41682342 | ||
DuoDERM hydroactive dressing versus silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns | Q42069074 | ||
Clinical evaluation of Epi-Lock--a semiocclusive dressing | Q42087608 | ||
Polyurethane film (Opsite) vs. impregnated gauze (Jelonet) in the treatment of outpatient burns: a prospective, randomized study | Q43716410 | ||
Outpatient management of partial-thickness burns: Biobrane versus 1% silver sulfadiazine | Q44660634 | ||
A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful? | Q46592508 | ||
Local therapy of grade IIa burns: efficacy and tolerability of a new hydrosome wound gel for the local treatment of grade IIa burns as compared with silver sulfadiazine ointment | Q46909397 | ||
Suprathel, a new skin substitute, in the management of partial-thickness burn wounds: results of a clinical study | Q47962658 | ||
A silicone-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. | Q50848939 | ||
Randomized clinical study of Hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns. | Q51208908 | ||
Biobrane versus duoderm for the treatment of intermediate thickness burns in children: a prospective, randomized trial. | Q51399790 | ||
Polyurethane and silver sulfadiazene dressings in treatment of partial-thickness burns and abrasions. | Q53748590 | ||
European comparative clinical study of Inerpan: A new wound dressing in treatment of partial skin thickness burns | Q67464460 | ||
Comparison of coarse mesh gauze with biologic dressings on granulating wounds | Q67523454 | ||
Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second-degree burns | Q68172231 | ||
Moisture-vapour-permeable film as an outpatient burn dressing | Q68361491 | ||
Biosynthetic Skin Substitute vs. 1% Silver Sulfadiazine for Treatment of Inpatient Partial-thickness Thermal Burns | Q68490416 | ||
Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second-degree burns | Q68876446 | ||
Burn wound dressings--a review | Q69119577 | ||
Preliminary report on the use of a new hydrocolloid dressing in the treatment of burns | Q70412289 | ||
Management of partial thickness burns with Granuflex 'E' dressings | Q70655388 | ||
Prospective, randomized study of the efficacy of pressure garment therapy in patients with burns | Q70826017 | ||
Report on evaluation of hydron film as burn wound dressing | Q71788451 | ||
Evaluation of hydrocolloids and topical medication in minor burns | Q71843729 | ||
Safety and efficacy of a new synthetic burn dressing: a multicenter study | Q72143111 | ||
Biobrane improves wound healing in burned children without increased risk of infection | Q73069975 | ||
Biobrane versus 1% silver sulfadiazine in second-degree pediatric burns | Q73337015 | ||
Prospective, randomized study of the efficacy of Mepitel on children with partial-thickness scalds | Q77117333 | ||
A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds | Q77663609 | ||
Assessing PTFE bags for the treatment of hand burns | Q88895543 | ||
Amniotic membrane is an effective burn dressing material | Q93579224 | ||
P577 | publication date | 2008-10-08 | |
P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
P1476 | title | Dressings for superficial and partial thickness burns |
Q38697618 | Agreement on what to measure in randomised controlled trials in burn care: study protocol for the development of a core outcome set. |
Q53161877 | An ultrathin poly(L-lactic acid) nanosheet as a burn wound dressing for protection against bacterial infection. |
Q92192341 | Antibacterial Activity of Chlorhexidine-Killed Bacteria: The Zombie Cell Effect |
Q24202058 | Antibiotic prophylaxis for preventing burn wound infection |
Q24235100 | Antibiotic prophylaxis for preventing burn wound infection |
Q37497078 | Assessment of Deep Partial Thickness Burn Treatment with Keratin Biomaterial Hydrogels in a Swine Model |
Q38920223 | Beyond conventional antibiotics - New directions for combination products to combat biofilm |
Q33947489 | Burns (minor thermal). |
Q47631510 | Commercial dressings for burns versus sweet ancient remedy. |
Q34088357 | Comparing oil based ointment versus standard practice for the treatment of moderate burns in Greece: a trial based cost effectiveness evaluation |
Q41821814 | Comparison of three different dressings for partial thickness burns in children: study protocol for a randomised controlled trial. |
Q41097380 | Cutaneous wound healing after treatment with plant-derived human recombinant collagen flowable gel |
Q24201470 | Early excision and grafting for burns |
Q64902159 | Effect of ointment-based egg white on healing of second- degree wound in burn patients: a triple-blind randomized clinical trial study. |
Q98770776 | Evaluation of EpiProtect® microbial cellulose burns dressings in young children |
Q33547194 | Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help? |
Q38046172 | Extremity trauma, dressings, and wound infection: should every acute limb wound have a silver lining? |
Q46743045 | Fibrin biomatrix-conjugated platelet-derived growth factor AB accelerates wound healing in severe thermal injury. |
Q38008034 | Hyaluronic acid derivatives and their healing effect on burns, epithelial surgical wounds, and chronic wounds: a systematic review and meta-analysis of randomized controlled trials |
Q42105562 | In vitro study of sustained antimicrobial activity of a new silver alginate dressing. |
Q24187407 | Interventions for treating leg ulcers in people with sickle cell disease |
Q24202954 | Interventions for treating leg ulcers in people with sickle cell disease |
Q24239921 | Interventions for treating leg ulcers in people with sickle cell disease |
Q38631932 | Patchwork Coating of Fragmented Ultra-Thin Films and Their Biomedical Applications in Burn Therapy and Antithrombotic Coating. |
Q36404809 | Pediatric burn injuries |
Q34669899 | Pressure ulcers: Current understanding and newer modalities of treatment |
Q42109695 | Pyocyanin production by Pseudomonas aeruginosa confers resistance to ionic silver |
Q36697587 | Silver toxicity with the use of silver-impregnated dressing and wound vacuum-assisted closure in an immunocompromised patient |
Q64236283 | Systematic review of clinical outcome reporting in randomised controlled trials of burn care |
Q42194844 | The effect of egg yolk oil in the healing of third degree burn wound in rats. |
Q37315475 | The evaluation and management of thermal injuries: 2014 update |
Q28077410 | The evidence for natural therapeutics as potential anti-scarring agents in burn-related scarring |
Q24236575 | Topical silver for preventing wound infection |
Q24201789 | Topical treatment for facial burns |
Q24241237 | Topical treatment for facial burns |
Search more.